Recent Finacing
Recent Raise
Specific Biologics develops a two-site Dualase gene-editing platform to create therapeutics for genetic diseases, focusing preclinical programs in liver, ocular, CNS disorders and cystic fibrosis.
Focus Areas
Recent Investors
Funding round
Investors
See the team members at Specific Biologics.
